Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$3.15

0.15 (5.00%)

16:20
11/18/16
11/18
16:20
11/18/16
16:20

Immunomedics confirms venBio's submitted notice of board director nominations

Immunomedics confirmed that venBio Select Advisor LLC has submitted a notice of nomination of four director candidates to stand for election to the Immunomedics board of directors at the company's 2016 Annual Meeting of Stockholders to be held on December 14, 2016. The company issued the following statement: "The Immunomedics Board of Directors and management team are committed to acting in the best interests of the company and all stockholders and regularly seeks qualified candidates for the Board. To that end, while venBio did not engage in discussions with the company prior to nominating a majority slate for election to the Board just four weeks prior to the upcoming 2016 Annual Meeting, Immunomedics' Governance and Nominating Committee will consider venBio's director candidates and respond in due course. Immunomedics has achieved a number of important milestones in 2016, including delivering positive Phase 2 clinical trial results of IMMU-132 in patients with metastatic triple-negative breast cancer, which have been submitted for publication; achieving our timetable for the manufacturing of clinical materials for the Phase 3 confirmatory trial in TNBC; and nearing completion of enrolling 100 patients into our ongoing open-label Phase 2 trial by year-end 2016. The company has also retained Greenhill & Co. to pursue licensing and other strategic activities with regard to preclinical and clinical pipeline products as well as platform technologies. The company is at a pivotal point in its growth trajectory as it prepares to submit an accelerated approval application to the FDA for IMMU-132 in mid-2017 and believes disruption in its strategy at this time could destroy value and potentially disrupt the company's clinical trial activities for late-stage cancer patients. Additionally, as previously announced, at the annual meeting of the American Society of Hematology in December 2016, the company will premiere a new antibody-drug conjugate known as IMMU-140 and the company anticipates delivering interim results for IMMU-132 at a symposium on genitourinary cancers to be held in early 2017. Immunomedics is well-positioned to execute on the company's strategy, drive innovation in the targeted treatment of cancer, autoimmune disorders and other serious diseases and enhance stockholder value, and perhaps most importantly help patients suffering from cancer."

IMMU Immunomedics
$3.15

0.15 (5.00%)

10/18/16
JEFF
10/18/16
NO CHANGE
JEFF
Jefferies sees 'attractive buying opportunities' in Biotech
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. While volatility will likely continue into the election, valuation multiples are near-historic lows and policy concerns, while valid, are likely overstated, the analysts tell investors in a research note. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment. Jefferies likes Gilead (GILD) and Celgene (CELG) among large-caps, The Medicines Co. (MDCO), Alkermes (ALKS) and Vertex (VRTX) among mid-caps, and Alder Biopharmaceuticals (ALDR), Cempra (CEMP), Ultragenyx (RARE) and Immunomedics (IMMU) among small-caps.
10/06/16
JEFF
10/06/16
INITIATION
Target $5.5
JEFF
Buy
Immunomedics assumed with a Buy at Jefferies
Jefferies analyst Matthew Andrews assumed coverage of Immunomedics with a Buy rating and raised his price target for the shares to $5.50 from $5. IMMU-132's "promising results" in Triple Negative breast cancer sets the stage for a partnership deal in the coming months, Andrews tells investors in a research note.
06/21/16
WELS
06/21/16
DOWNGRADE
WELS
Market Perform
Immunomedics downgraded to Market Perform from Outperform at Wells Fargo
05/06/16
JEFF
05/06/16
UPGRADE
Target $5
JEFF
Buy
Immunomedics upgraded to Buy from Hold at Jefferies
Jefferies analyst Chris Howerton upgraded Immunomedics to Buy saying IMMU-132 continues to demonstrate impressive clinical data in solid tumors. The analyst sees a greater likelihood of Immunomedics securing a partner for the asset following recent data. He raised his price target for the shares to $5.00 from $1.50.

TODAY'S FREE FLY STORIES

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

, UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

21:49
02/20/17
02/20
21:49
02/20/17
21:49
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

UL

Unilever; also tag UN

$48.53

5.96 (14.00%)

BRK.A

Berkshire Hathaway

$252,838.00

1338 (0.53%)

BRK.B

Berkshire Hathaway

$168.57

0.83 (0.49%)

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

GIS

General Mills

$59.23

-2.31 (-3.75%)

QSR

Restaurant Brands

$53.90

0.05 (0.09%)

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

LMOS

Lumos Networks

$15.23

0.09 (0.59%)

CYH

Community Health

$6.90

-0.22 (-3.09%)

NDSN

Nordson

$119.95

0.77 (0.65%)

TWX

Time Warner

$96.48

0.09 (0.09%)

CMCSA

Comcast

$75.32

-0.67 (-0.88%)

CMCSK

Comcast

GM

General Motors

$37.22

0.19 (0.51%)

ADNT

Adient

$64.01

-0.69 (-1.07%)

HD

Home Depot

$143.00

1.46 (1.03%)

TOSBF

Toshiba, also use TOSYY

$1.61

-0.182 (-10.17%)

TOSYY

Toshiba, also use TOSBF

$9.55

-1.085 (-10.21%)

ANTM

Anthem

$160.25

-3.52 (-2.15%)

SYF

Synchrony

$36.68

-0.17 (-0.46%)

HES

Hess Corp.

$51.75

0.45 (0.88%)

DIN

DineEquity

$60.14

-6.41 (-9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 06

    Mar

  • 15

    Mar

  • 19

    Mar

  • 21

    Mar

  • 23

    Mar

AAPL

Apple

$135.72

0.375 (0.28%)

, AMZN

Amazon.com

$845.07

0.93 (0.11%)

21:01
02/20/17
02/20
21:01
02/20/17
21:01
Periodicals
Apple 'has no apparent interest' in copying Amazon Echo, Time says »

Apple (AAPL) "has no…

AAPL

Apple

$135.72

0.375 (0.28%)

AMZN

Amazon.com

$845.07

0.93 (0.11%)

GOOG

Alphabet

$828.07

3.91 (0.47%)

GOOGL

Alphabet Class A

$846.55

4.38 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

  • 06

    Mar

  • 13

    Mar

  • 14

    Mar

  • 19

    Mar

  • 28

    Mar

SNAP

Snap Inc

20:58
02/20/17
02/20
20:58
02/20/17
20:58
Hot Stocks
Snap Inc launches online sales of 'Spectacles' »

Snap Inc has introduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

AMZN

Amazon.com

$845.07

0.93 (0.11%)

20:54
02/20/17
02/20
20:54
02/20/17
20:54
Hot Stocks
Amazon reduces free shipping threshold to $35 »

Amazon has lowered its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 14

    Mar

  • 19

    Mar

  • 28

    Mar

FB

Facebook

$133.53

-0.31 (-0.23%)

20:49
02/20/17
02/20
20:49
02/20/17
20:49
Hot Stocks
Facebook subsidiary WhatsApp launches 'Status' »

Facebook messaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

MSFT

Microsoft

$64.62

0.1 (0.15%)

, AMZN

Amazon.com

$845.07

0.93 (0.11%)

20:46
02/20/17
02/20
20:46
02/20/17
20:46
Hot Stocks
Microsoft, Flipkart announce strategic partnership, cloud computing deal »

Microsoft (MSFT) and…

MSFT

Microsoft

$64.62

0.1 (0.15%)

AMZN

Amazon.com

$845.07

0.93 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 14

    Mar

  • 19

    Mar

  • 28

    Mar

  • 09

    May

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

, UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

20:43
02/20/17
02/20
20:43
02/20/17
20:43
Periodicals
3G Capital hunting for 'major takeover,' has up to $15B to deploy, FT says »

3G Capital has as much as…

KHC

Kraft Heinz

$96.65

9.37 (10.74%)

UN

Unilever; also tag UL

$48.79

6.47 (15.29%)

UL

Unilever; also tag UN

$48.53

5.96 (14.00%)

MDLZ

Mondelez

$42.50

-0.7 (-1.62%)

K

Kellogg

$72.90

-1.81 (-2.42%)

GIS

General Mills

$59.23

-2.31 (-3.75%)

CPB

Campbell Soup

$58.48

-4.07 (-6.51%)

CL

Colgate-Palmolive

$71.98

2.98 (4.32%)

KMB

Kimberly-Clark

$131.93

5.31 (4.19%)

CLX

Clorox

$133.71

3.61 (2.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 19

    Mar

DEPO

Depomed

$16.47

-0.38 (-2.26%)

20:39
02/20/17
02/20
20:39
02/20/17
20:39
Downgrade
Depomed rating change  »

Depomed downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

PTEN

Patterson-UTI

$27.43

-0.33 (-1.19%)

20:39
02/20/17
02/20
20:39
02/20/17
20:39
Upgrade
Patterson-UTI rating change  »

Patterson-UTI upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SABR

Sabre

20:39
02/20/17
02/20
20:39
02/20/17
20:39
Downgrade
Sabre rating change  »

Sabre downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

EQM

EQT Midstream Partners

$81.91

-0.28 (-0.34%)

20:39
02/20/17
02/20
20:39
02/20/17
20:39
Upgrade
EQT Midstream Partners rating change  »

EQT Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$49.19

0.73 (1.51%)

20:34
02/20/17
02/20
20:34
02/20/17
20:34
Hot Stocks
Verizon introduces 2GB prepaid wireless plan »

Verizon announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

GOOG

Alphabet

$828.07

3.91 (0.47%)

, GOOGL

Alphabet Class A

$846.55

4.38 (0.52%)

20:32
02/20/17
02/20
20:32
02/20/17
20:32
Periodicals
YouTube to end unskippable 30-second ads in 2018, The Verge says »

Alphabet's YouTube…

GOOG

Alphabet

$828.07

3.91 (0.47%)

GOOGL

Alphabet Class A

$846.55

4.38 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

  • 19

    Mar

TOSBF

Toshiba, also use TOSYY

$1.61

-0.182 (-10.17%)

, TOSYY

Toshiba, also use TOSBF

$9.55

-1.085 (-10.21%)

20:29
02/20/17
02/20
20:29
02/20/17
20:29
Periodicals
Toshiba wants to raise at least $8.8B from chip unit stake, Reuters says »

Toshiba wants to raise…

TOSBF

Toshiba, also use TOSYY

$1.61

-0.182 (-10.17%)

TOSYY

Toshiba, also use TOSBF

$9.55

-1.085 (-10.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFOI

Energy Focus

$4.50

-0.21 (-4.46%)

20:25
02/20/17
02/20
20:25
02/20/17
20:25
Hot Stocks
Energy Focus says CEO Tu steps down, Tewksbury appointed as chairman, CEO »

Energy Focus announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

WMT

Wal-Mart

$69.37

0.5 (0.73%)

, M

Macy's

$32.30

0.48 (1.51%)

20:25
02/20/17
02/20
20:25
02/20/17
20:25
Earnings
Notable companies reporting before Tuesday's open »

Notable companies…

WMT

Wal-Mart

$69.37

0.5 (0.73%)

M

Macy's

$32.30

0.48 (1.51%)

HD

Home Depot

$143.00

1.46 (1.03%)

SNI

Scripps Networks

$76.04

-1.06 (-1.37%)

MDT

Medtronic

$78.88

0.89 (1.14%)

LL

Lumber Liquidators

$15.36

-0.3 (-1.92%)

GPC

Genuine Parts

$100.67

1.44 (1.45%)

ECL

Ecolab

$123.95

0.67 (0.54%)

CBRL

Cracker Barrel

$168.69

1.14 (0.68%)

AAP

Advance Auto Parts

$161.58

0.59 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 14

    Mar

  • 15

    Mar

  • 17

    Mar

  • 19

    Mar

  • 21

    Mar

IOC

InterOil

$48.39

0.07 (0.14%)

, XOM

Exxon Mobil

$81.76

-0.54 (-0.66%)

20:22
02/20/17
02/20
20:22
02/20/17
20:22
Hot Stocks
InterOil says Yukon approves Exxon Mobil transaction, sees completion this week »

InterOil (IOC) announced…

IOC

InterOil

$48.39

0.07 (0.14%)

XOM

Exxon Mobil

$81.76

-0.54 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$96.48

0.09 (0.09%)

, CMCSA

Comcast

$75.32

-0.67 (-0.88%)

20:19
02/20/17
02/20
20:19
02/20/17
20:19
Hot Stocks
Box Office Battle: 'Lego Batman' fends off China co-production 'Great Wall' »

Against analyst estimates…

TWX

Time Warner

$96.48

0.09 (0.09%)

CMCSA

Comcast

$75.32

-0.67 (-0.88%)

CMCSK

Comcast

LGF.A

Lionsgate

$27.52

-0.18 (-0.65%)

LGF.B

Lionsgate

$25.81

-0.28 (-1.07%)

FOX

21st Century Fox

$29.92

-0.16 (-0.53%)

FOXA

21st Century Fox

$30.35

-0.16 (-0.52%)

DIS

Disney

$110.06

-0.65 (-0.59%)

SNE

Sony

$31.34

0.04 (0.13%)

VIA

Viacom

$47.00

-0.2 (-0.42%)

VIAB

Viacom

$43.99

-0.17 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 09

    Mar

  • 10

    Mar

HLX

Helix Energy

$7.41

-0.32 (-4.14%)

19:24
02/20/17
02/20
19:24
02/20/17
19:24
Earnings
Helix Energy reports Q4 EPS with items (46c), may not compare to consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CSII

Cardiovascular Systems

$29.19

0.76 (2.67%)

19:21
02/20/17
02/20
19:21
02/20/17
19:21
Hot Stocks
Cardiovascular Systems reports one-year data from COAST study »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMT

America's Car-Mart

$38.85

-1.15 (-2.88%)

19:17
02/20/17
02/20
19:17
02/20/17
19:17
Earnings
America's Car-Mart reports Q3 EPS 35c, may not compare to consensus 64c »

Reports Q3 revenue $139M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ROG

Rogers Corporation

$78.80

-1.34 (-1.67%)

19:12
02/20/17
02/20
19:12
02/20/17
19:12
Earnings
Rogers Corporation sees Q1 adjusted EPS $1.09-$1.19, consensus 99c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

ROG

Rogers Corporation

$78.80

-1.34 (-1.67%)

19:11
02/20/17
02/20
19:11
02/20/17
19:11
Earnings
Rogers Corporation reports Q4 EPS 94c, consensus 82c »

Reports Q4 revenue $173M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

HBHC

Hancock Holding

$46.80

-0.2 (-0.43%)

, FNBC

First NBC Bank

$4.75

-0.25 (-5.00%)

19:04
02/20/17
02/20
19:04
02/20/17
19:04
Hot Stocks
Hancock Holding says gets approval to close First NBC Bank transaction »

Hancock Holding (HBHC)…

HBHC

Hancock Holding

$46.80

-0.2 (-0.43%)

FNBC

First NBC Bank

$4.75

-0.25 (-5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$119.95

0.77 (0.65%)

19:03
02/20/17
02/20
19:03
02/20/17
19:03
Earnings
Nordson sees Q2 EPS $1.21-$1.33, consensus $1.22 »

Sees Q2 revenue up 3%-7%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.